[Frontalis suspension using autogenous fascia lata--evaluation of long-term outcome].
OBJECTIVE
To evaluate long-term outcome of frontalis suspension using autogenous fascia lata (frontalis suspension - FS) which is indicated in the treatment of severe blepharoptosis with minimal levator function.


METHODS
Fourty one patients (23 females, 18 males, aged 6-79 years, mean 41.4 years) who underwent FS between 1999 and 2009 were evaluated. Mean follow-up was 55 months. Functional outcome was measured on digital photographs by analysis of an upper eyelid margin position below the superior limbus. Following criteria were used: very good (< 3 mm), good (3-5 mm), unsatisfactory (> 5 mm). Aesthetic outcome was assessed in terms of lid contour, symmetry of lid height and lid crease. Patient satisfaction and life quality improvement were evaluated in the survey.


RESULTS
Functional outcome was very good in 36%, good in 59.3%, unsatisfactory in 4.7%. Recurrence occured in 4.6% and complications in 10.9% (lagophthalmos--6.2%, entropion--4.7%). Very good aesthetic outcome regarding lid contour, symmetry of lid height and lid crease was achieved in 76.6%, 53.6% and 51.6%, respectively. Patient satisfaction and life quality improvement was also very high. There were only 1.6% unsatisfied patients.


CONCLUSIONS
FS is an efficient method in treatment of severe blepharoptosis.
Klinika Chirurgii Plastycznej, Centrum Medycznego Kształcenia Podyplomowego w Warszawie. tdebski@o2.pl
Tomasz
T
Debski
Józef
J
Jethon
Piotr
P
Pietruski
Elzbieta
E
Radzikowska
D000293:Adolescent; D000328:Adult; D000368:Aged; D001763:Blepharoptosis / Q000151:congenital / Q000601:surgery*; D002648:Child; D004954:Esthetics; D005143:Eyelids / Q000601:surgery*; D005206:Fascia Lata / Q000637:transplantation*; D005260:Female; D005500:Follow-Up Studies; D006801:Humans; D008297:Male; D008875:Middle Aged; D009801:Oculomotor Muscles / Q000601:surgery*; D017060:Patient Satisfaction; D011044:Poland; D011788:Quality of Life; D012189:Retrospective Studies; D055502:Secondary Prevention; D014182:Transplantation, Autologous; D016896:Treatment Outcome; D055815:Young Adult